ClinVar Miner

Submissions for variant NM_001127222.2(CACNA1A):c.4096T>A (p.Phe1366Ile)

dbSNP: rs1057520749
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000433673 SCV000517283 pathogenic not provided 2015-06-04 criteria provided, single submitter clinical testing The F1367I variant in the CACNA1A gene has not been reported previously as a pathogenic variant nor as a benign polymorphism, to our knowledge. The F1367I substitution was not observed in approximately 6200 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The F1367I variant is a conservative amino acid substitution, which occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same (F1367L) and nearby residues (R1359W and C1369Y) have been reported in the Human Gene Mutation Database in association with CACNA1A-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret F1367I as a pathogenic variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.